131 related articles for article (PubMed ID: 27449629)
21. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
[TBL] [Abstract][Full Text] [Related]
22. Activity and Safety of Inhaled Itraconazole Nanosuspension in a Model Pulmonary Aspergillus fumigatus Infection in Inoculated Young Quails.
Wlaź P; Knaga S; Kasperek K; Wlaź A; Poleszak E; Jeżewska-Witkowska G; Winiarczyk S; Wyska E; Heinekamp T; Rundfeldt C
Mycopathologia; 2015 Aug; 180(1-2):35-42. PubMed ID: 25790942
[TBL] [Abstract][Full Text] [Related]
23. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
[TBL] [Abstract][Full Text] [Related]
25. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia).
Averina ES; Müller RH; Popov DV; Radnaeva LD
Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068
[TBL] [Abstract][Full Text] [Related]
26. Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.
Kaur R; Dennison SR; Burrow AJ; Rudramurthy SM; Swami R; Gorki V; Katare OP; Kaushik A; Singh B; Singh KK
J Nanobiotechnology; 2021 Jan; 19(1):19. PubMed ID: 33430888
[TBL] [Abstract][Full Text] [Related]
27. Development of nanostructured lipid carriers for intraoral delivery of Domperidone.
Tetyczka C; Griesbacher M; Absenger-Novak M; Fröhlich E; Roblegg E
Int J Pharm; 2017 Jun; 526(1-2):188-198. PubMed ID: 28461264
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
29. Inhalable highly concentrated itraconazole nanosuspension for the treatment of bronchopulmonary aspergillosis.
Rundfeldt C; Steckel H; Scherliess H; Wyska E; Wlaź P
Eur J Pharm Biopharm; 2013 Jan; 83(1):44-53. PubMed ID: 23064325
[TBL] [Abstract][Full Text] [Related]
30. Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery.
Andrade LM; Rocha KA; De Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF
Cornea; 2016 Jun; 35(6):866-71. PubMed ID: 27055213
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
32. NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols.
Pornputtapitak W; El-Gendy N; Berkland C
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):341-52. PubMed ID: 25679514
[TBL] [Abstract][Full Text] [Related]
33. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
34. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
35. Development, characterization and evaluation of doxorubicin nanostructured lipid carriers for prostate cancer.
Zhang HW; Dang Q; Zhang ZW; Wu FS
J BUON; 2017; 22(1):102-111. PubMed ID: 28365942
[TBL] [Abstract][Full Text] [Related]
36. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
38. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
39. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
40. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
